Select your language

Other official information and services: www.belgium.be  Logo Belgium

1. Key messages

  • In 2024, 662 people were newly diagnosed with HIV in Belgium, with the total number remaining stable compared to 2023.
  • An increase was observed among Belgian men, both heterosexual and men who have sex with men (MSM).
  • 289 MSM were newly diagnosed, the same as in 2023, but diagnoses among Belgian MSM rose by 15%.
  • 332 heterosexual people were newly diagnosed (175 women and 157 men), a 3% increase from 2023. Among women, diagnoses remained stable for Belgian women but decreased for women of other nationalities. Among men, diagnoses increased, with a 33% rise specifically among Belgian heterosexual men.
  • Overall, the epidemic mainly affects Belgian MSM and heterosexual men and women from sub-Saharan Africa.
  • Brussels remains disproportionately affected, with a diagnosis rate almost three times higher than the national average.

2. New diagnoses of HIV infections in 2024

In 2024, 662 new diagnoses of HIV infections were made in Belgium (5.6 new diagnoses per 100.000 inhabitants, or on average 1.8 cases a day). Among those, 71% were men. 75% of the HIV infections were diagnosed in people aged 20-49.

Number of new reported HIV diagnoses by age and sex, Belgium, 2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

New HIV diagnoses have increased for 4 consecutive years (2021-2024)

The number of new HIV diagnoses in 2024 is similar to that of 2023 (+2%). An increase in the number of new HIV diagnoses has been observed over the last four years, following a steady decline in the years preceding the COVID-19 pandemic.

Between the start of the epidemic in the early 80s and the end of 2024, a total of 32,401 persons were diagnosed with HIV, and a total of 5,742 cases of AIDS were reported.

Number of new diagnoses of HIV and AIDS, Belgium, 1986-2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

Brussels has a higher diagnosis rate compared to the rest of Belgium

In 2024, of the 662 newly diagnosed persons, 201 were resident in the Brussels-Capital Region, 273 in the Flemish Region, 179 in the Walloon Region, and 9 were residing abroad.

When accounting for the number of inhabitants, the incidence rates in the Flemish Region (max 7 for 100,000 inhabitants in Ostende district) and in the Walloon Region (max 8/100,000 in Arlon; 7/100,000 in Tournai-Mouscron and Bergen districts) are comparable, while the rate in the Brussels Capital Region is still much higher (16/100,000).This difference is not surprising since a higher HIV prevalence is a common phenomenon in a big city. The Brussels Capital Region can indeed be considered a big city - with the socio-cultural characteristics of an urban context – while the two other regions mix rural, semi-urban, and urban contexts. In addition, Brussels has specific characteristics as a capital city, with high international population mobility and an overrepresentation of certain population groups at higher risk.

Rate of new HIV diagnoses per 100,000 by region, Belgium, 2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

Continued increase in new diagnoses observed in the Walloon Region from 2021 to 2024

Following a decline over the previous decade, an increase in newly diagnosed people in the last three years was observed at national level in all three regions. This increased continued only in the Walloon Region in 2024.

Number of new HIV diagnoses by region, Belgium, 2009-2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

Diversification in the 2-key populations in Belgium

The HIV epidemic in Belgium mainly affects two populations: men who have sex with men (MSM), mostly of Belgian nationality, and men and women who have contracted the virus through heterosexual intercourse, mainly from sub-Saharan Africa.

Number of new HIV diagnoses by probable mode of infection, Belgium, 1999-2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

However, among both MSM and heterosexuals, the distribution of nationalities changes significantly over time. In 2024, 289 new HIV diagnoses were made among MSM, the same number as 2023. Among them, diagnoses among MSM of Belgian nationality increased by 15% compared with 2023; representing 56% of HIV diagnoses among MSM in 2024. In addition, 15% of MSM diagnosed had another European nationality and 14% had a Latin American nationality.

In 2024, 332 HIV diagnoses were reported among heterosexual people, a number similar to 2023 (+3%). Among women (175), there was a slight decrease (–5%), while an increase was observed among men (157; +13%). The number of diagnoses remained stable among Belgian women but decreased among women of other nationalities. Among men, the overall increase was mainly driven by Belgian men (+33%) and, to a lesser extent, by men of other nationalities.

  • MSM
  • Heterosexuals

Number of new HIV diagnoses in MSM by nationality, Belgium, 1995-2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

Number of new HIV diagnoses in heterosexuals by nationality, Belgium, 1995-2024
Source: Epidémiologie du SIDA et de l’infection à VIH en Belgique, Sciensano, 2025 [1]

Close to 20,000 persons were living with HIV in Belgium in 2024

By the end of 2024, an estimated 19,183 individuals were living with HIV in Belgium. Among them, 94% had received a diagnosis, and of those diagnosed, 95% were undergoing antiretroviral treatment, and of those on treatment, 98% had reached viral suppression, accounting for 88% of all people living with HIV.

More than a thousand people in Belgium live with an undiagnosed HIV infection

In 2024, Sciensano estimated the number of people living with undiagnosed HIV [1] based on a tool developed by ECDC [2]. It is estimated that 1224 people living with HIV in Belgium were unaware of their HIV status. However, these estimates should be interpreted with caution given the significant uncertainty surrounding the estimates for the last 3 years derived from this model. Based on the ECDC tool, the number of people living with undiagnosed HIV in Belgium appears to have been steadily declining since 2011.

3. Read more

View the metadata for this indicator

HIV Surveillance - Sciensano

Background

Transmission of HIV

Sexually transmitted infections (STIs) such as human immunodeficiency virus (HIV) are spread primarily through person-to-person sexual contact. Additionally, HIV can be transmitted through blood products – such as drug injection - and tissue transfer, and perinatally during pregnancy or breastfeeding.

HIV can be present without symptoms, which can facilitate transmission. It is one of the most serious communicable diseases in Europe. Infection with the virus can, if antiretroviral treatment (ART) is not initiated, lead to serious morbidity (Acquired Immunodeficiency Syndrome (AIDS)) and requires life-long treatment.

HIV is an avoidable infection since the transmission is largely preventable by behavioural measures (safe sex, safe injection). Therefore HIV incidence in a defined population is an indicator of the success/failure of control strategies. Since 2017, the use of pre-exposure prophylaxis to HIV (PrEP) is reimbursed in Belgium.

Surveillance of HIV in Belgium

The epidemiological surveillance of HIV in Belgium dates from 1985 and is carried out by Sciensano on the basis of the registration of new HIV diagnoses. These data are reported by the seven AIDS reference laboratories that perform all confirmations of positive HIV screening tests. In addition to recording the number of newly diagnosed HIV positive persons, the laboratories also collect basic epidemiological data on sex, age, nationality, probable route of infection, and clinical stage at the time of diagnosis. Sciensano also collects data on the people living with HIV (PLWH) in care in Belgium (HIV cohort data) from the AIDS reference laboratories and the HIV reference centres.

Besides the newly diagnosed cases, Sciensano also estimates the number of people living with HIV: those who have not yet been diagnosed [1] and those living with a diagnosed infection. To estimate the undiagnosed population an instrument developed by the European Center for Disease Prevention and Control (ECDC), called the ECDC HIV Modeling Tool [2] is used. HIV cohort data are used to estimate the number of people living with a diagnosed infection.

ECDC and the WHO Regional Office for Europe jointly coordinate HIV/AIDS surveillance in Europe [3]. The international comparability has some limitations since the national surveillance systems differ in levels of underreporting and reporting delay.

Definitions

New HIV diagnoses
A new HIV diagnosis is defined as a first HIV diagnosis. People, mainly foreigners, with an HIV diagnosis or in care for HIV in another country before their diagnosis was confirmed in Belgium are treated separately. People with known HIV infection do not represent a population that could have benefited from prevention measures in Belgium and are therefore presented separately. More information on them can be found in the annual epidemiological report.
HIV/AIDS
HIV infection and AIDS are the acronyms of "Human Immunodeficiency Virus" (HIV) infection and "Acquired Immune Deficiency Syndrome" (AIDS). Initial HIV infection is most often asymptomatic, while people may experience influenza-like symptoms. This is followed by a prolonged period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing infections such as tuberculosis, as well as other opportunistic infections, and tumours which are rare in people who have a normal immune function. These late symptoms of infection are referred to as AIDS. Since the late 1990s, efficient antiretroviral treatment exists that can control the progression of the disease.

References

[1] Epidémiologie du VIH en Belgique. Situation au 31 décembre 2024. Bruxelles: Sciensano; 2025. https://www.sciensano.be/fr/biblio/epidemiologie-du-vih-en-belgique-situation-au-31-decembre-2024

[2] European Centre for Disease Prevention and Control. HIV Modelling Tool. 2015. https://www.ecdc.europa.eu/en/publications-data/hiv-modelling-tool

[3] European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2025 – 2024 data. Stockholm: ECDC; 2025. https://www.who.int/europe/publications/i/item/9789289062671

Please cite this page as: Sciensano. Communicable Diseases: HIV, Health Status Report, 8 Jan 2026, Brussels, Belgium, https://www.healthybelgium.be/en/health-status/communicable-diseases/hiv-and-other-sexually-transmitted-infections